BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30986917)

  • 21. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
    Herrlinger KR; Diculescu M; Fellermann K; Hartmann H; Howaldt S; Nikolov R; Petrov A; Reindl W; Otte JM; Stoynov S; Strauch U; Sturm A; Voiosu R; Ammendola A; Dietrich B; Hentsch B; Stange EF
    J Crohns Colitis; 2013 Sep; 7(8):636-43. PubMed ID: 23078909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum trefoil factors in patients with inflammatory bowel disease.
    Grønbaek H; Vestergaard EM; Hey H; Nielsen JN; Nexø E
    Digestion; 2006; 74(1):33-9. PubMed ID: 17068395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.
    Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO
    J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
    Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.
    Dierckx T; Verstockt B; Vermeire S; van Weyenbergh J
    J Crohns Colitis; 2019 Mar; 13(3):389-394. PubMed ID: 30312386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status.
    Ates Y; Degertekin B; Erdil A; Yaman H; Dagalp K
    Dig Dis Sci; 2008 Aug; 53(8):2215-21. PubMed ID: 18080768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
    Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
    J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.
    Neubauer K; Woźniak-Stolarska B; Krzystek-Korpacka M
    Biomed Res Int; 2018; 2018():4961753. PubMed ID: 30515402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
    Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
    Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B
    Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients.
    Thia KT; Li M; Ling KL; Kong SC; Ooi CJ
    Inflamm Bowel Dis; 2011 Mar; 17(3):809-15. PubMed ID: 20645318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
    De La Fuente M; Chahuán I; Gutiérrez R; Díaz-Jiménez D; Olivares M; Vidal R; Simian D; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2017 Sep; 145(9):1129-1136. PubMed ID: 29424399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C; Fournier N; Pittet V; Dudler J; Michetti P
    Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.